Latest Period
Q4 2025
Security Snapshot
Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY) Institutional Ownership
CUSIP: 79400X503
13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025
Institutions Reporting
9
Shares (Excl. Options)
79,250
Price
$0.65
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- DCOY on Nasdaq
- Shares outstanding
- 7,157,222
- Price per share
- $0.66
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 79,250
- Total reported value
- $51,429
- % of total 13F portfolios
- 0%
- Share change
- +78,713
- Value change
- +$49,570
- Number of holders
- 9
- Price from insider filings
- $0.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- DCOY - Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 79400X503.
- 9 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 5 to 9 between Q3 2025 and Q4 2025.
- Reported value moved from $1,977 to $51,429.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 79400X503?
CUSIP 79400X503 identifies DCOY - Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 79400X503:
Significant Owners of Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $885,706 | +$432,582 | 708,565 | +95% | CVI Investments, Inc. | 31 Dec 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $711,721 | 187,295 | Mitchell P. Kopin | 12 Nov 2025 |
As of 31 Dec 2025, 9 institutional investors reported holding 79,250 shares of Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY). This represents 1.1% of the company’s total 7,157,222 outstanding shares.